Chengqing (Alan) Wu
About Chengqing (Alan) Wu
Chengqing (Alan) Wu is the Head of Statistics for Hematology Clinical Development at BeiGene, with over 18 years of experience in statistics and clinical development.
Title and Current Role
Chengqing (Alan) Wu currently serves as the Head of Statistics for Hematology Clinical Development at BeiGene. Positioned in Summit, he leads the statistical efforts for hematology clinical development projects within the company. His role involves overseeing statistical strategy and ensuring the scientific rigor of clinical trials.
Professional Experience
Chengqing (Alan) Wu has a robust professional background, having accumulated over 18 years of experience in statistics and clinical development. Before joining BeiGene in July 2021, he was the Senior Director of Statistics at Bristol Myers Squibb from 2019 to 2021, where he contributed to hematology clinical development projects. Prior to that, he worked as the Director of Statistics at Celgene from 2011 to 2019. His academic experience includes a significant tenure as an Associate Research Scientist at Yale University from 2007 to 2011 and a Postdoctoral Visiting Fellow at the National Institutes of Health from 2003 to 2007.
Educational Background
Chengqing (Alan) Wu holds a Ph.D. in Statistics from the University of Science and Technology of China. He also earned a Bachelor of Science degree in Mathematics from the same institution. His educational background provides a solid foundation in both mathematics and statistics, supporting his extensive career in clinical development and statistical analysis.
Industry and Academic Experience
Chengqing (Alan) Wu has a diverse background spanning both industry and academia. His academic career includes research roles at Yale University and the National Institutes of Health, where he developed his expertise in scientific research and statistical analysis. Transitioning to the pharmaceutical industry, he held key positions at Celgene and Bristol Myers Squibb, further enhancing his experience in clinical development and statistics.